Biohaven Ltd. signs $80M licensing deal with Ono.
- $80M upfront payment from Ono.
- Royalties of 20% on net sales in Asia.
- BHV-1300 in Phase 3 for Graves' Disease.
Every EDGAR filing for Biohaven Ltd. (BHVN), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 10 · 10-Q expected ~Nov 10 (deadline Nov 9)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Kimberly Gentile, insider filing for BHVN
Kimberly Gentile, reporting
John Yetimoglu, new insider at BHVN
John Yetimoglu, reporting
Ownership stake disclosure by Woodline Partners LP
Woodline Partners LP, filed by
Warren Karl Volles, new insider at BHVN
Warren Karl Volles, reporting
Ownership stake disclosure by Janus Henderson Group Ltd. (amended)
Janus Henderson Group Ltd., filed by
Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
Kishan Mehta, insider filing for BHVN
Kishan Mehta, reporting
Kishan Mehta, insider filing for BHVN
Kishan Mehta, reporting
John W Childs, insider filing for BHVN (amended)
John W Childs, reporting
Matthew Buten, insider filing for BHVN
Matthew Buten, reporting
Ownership stake disclosure by SUVRETTA CAPITAL MANAGEMENT, LLC (amended)
SUVRETTA CAPITAL MANAGEMENT, LLC, filed by
Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
Kimberly Gentile, insider filing for BHVN
Kimberly Gentile, reporting
Ownership stake disclosure by JANUS HENDERSON GROUP PLC
JANUS HENDERSON GROUP PLC, filed by